Trials / Completed
CompletedNCT04830059
The Joint Effect of Air Pollution and Exercise on Cognitive Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Tsinghua University · Academic / Other
- Sex
- All
- Age
- 20 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
A double-blind randomized controlled trial design is used in this study. A mixed design of 2 (pollution reduction group vs. no pollution reduction group) × 3 (high intensity intermittent exercise \[HIIT\], moderate intensity of aerobic exercise \[MICT\] and control group \[CONT\]) is used. 93 subjects recruited by advertising will be randomly divided into 6 groups: high intensity exercise group (pollution reduction vs no pollution reduction), moderate intensity aerobic exercise group (pollution reduction vs no pollution reduction) and Stretching group (Control) (pollution reduction vs no pollution reduction).
Detailed description
Environmental intervention program In the pollution reduction groups, the air purification system is used 2 hours before the subjects entered the room to minimize the indoor PM2.5 and PM10. Exercise intervention program including HIIT, MICT and Stretching (Control) group : The VO2max of all subjects are measured one week before the experiment. HIIT program: 20 minutes exercise of HIIT (1min of 100% VO2max and 1min of 50% VO2max alternately) and 10 minutes of warm-up and relaxation. MICT program: 20 minutes exercise of 70-75% VO2max and 10 minutes of warm-up and relaxation. Stretching control group: 30 minutes of stretching, posture adjustment and rehabilitation courses taught by professional therapists.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise | Two types of exercise intervention and control group |
| BEHAVIORAL | Air purification | Air purification in order to reduce the PM2.5 and PM10 |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-10-30
- Completion
- 2021-12-30
- First posted
- 2021-04-02
- Last updated
- 2025-12-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04830059. Inclusion in this directory is not an endorsement.